Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model
Open Access
- 12 August 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (12), 4179-4189
- https://doi.org/10.1096/fj.08-112060
Abstract
Our objectives were 1) to characterize angiogenesis in the MDA‐MB‐435 xenograft mouse model with three‐dimensional (3D) MR molecular im aging using α5β1(RGD)‐ or irrelevant RGS‐targeted paramagnetic ...Keywords
Funding Information
- National Cancer Institute
- National Heart, Lung, and Blood Institute
This publication has 49 references indexed in Scilit:
- Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbitsThe FASEB Journal, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticleThe FASEB Journal, 2005
- Improved Tumor Targeting of Radiolabeled RGD Peptides Using Rapid Dose FractionationCancer Biotherapy & Radiopharmaceuticals, 2004
- Detection of Injury-Induced Vascular Remodeling by Targeting Activated α v β 3 Integrin In VivoCirculation, 2004
- Molecular Basis of Ligand Recognition by Integrin α5β1Published by Elsevier BV ,2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal Of Cancer, 1996
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990